UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.254

Sortiert nach

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Bioorganic & medicinal chemistry, 2021-07, Vol.42, p.116266-116266, Article 116266

2021

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss

Bioorganic & medicinal chemistry, 2023-01, Vol.78, p.117133, Article 117133

2023

Link zum Volltext

Verfügbarkeit prüfen

VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents

Bioorganic & medicinal chemistry, 2020-03, Vol.28 (5), p.115328, Article 115328

2020

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117726-117726, Article 117726

2024

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors

Bioorganic & medicinal chemistry, 2023-01, Vol.78, p.117152, Article 117152

2023

Link zum Volltext

Verfügbarkeit prüfen

Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action

Bioorganic & medicinal chemistry, 2017-02, Vol.25 (3), p.1066-1075

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential

Bioorganic & medicinal chemistry, 2021-11, Vol.50, p.116453, Article 116453

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, structural study and antitumor activity of novel alditol-based imidazophenanthrolines (aldo-IPs)

Bioorganic & medicinal chemistry, 2024-02, Vol.99, p.117563-117563, Article 117563

2024

Link zum Volltext

Verfügbarkeit prüfen

Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy

Bioorganic & medicinal chemistry, 2017-08, Vol.25 (15), p.4100-4109

2017

Link zum Volltext

Verfügbarkeit prüfen

Regioselective synthesis and in vitro cytotoxicity evaluation of 3-thiooxindole derivatives: Tubulin polymerization inhibition and apoptosis inducing studies

Bioorganic & medicinal chemistry, 2023-07, Vol.90, p.117297-117297, Article 117297

2023

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents

Bioorganic & medicinal chemistry, 2010-05, Vol.18 (10), p.3543-3550

2010

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors

Bioorganic & medicinal chemistry, 2022-11, Vol.74, p.117067-117067, Article 117067

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents

Bioorganic & medicinal chemistry, 2023-03, Vol.82, p.117234-117234, Article 117234

2023

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer

Bioorganic & medicinal chemistry, 2024-01, Vol.98, p.117584-117584, Article 117584

2024

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones

Bioorganic & medicinal chemistry, 2022-04, Vol.60, p.116626-116626, Article 116626

2022

Link zum Volltext

Verfügbarkeit prüfen

Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117734-117734, Article 117734

2024

Link zum Volltext

Verfügbarkeit prüfen

Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells

Bioorganic & medicinal chemistry, 2024-04, Vol.103, p.117655-117655, Article 117655

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel naphthoquinone-1H-1,2,3-triazole hybrids: Design, synthesis and evaluation as inductors of ROS-mediated apoptosis in the MCF-7 cells

Bioorganic & medicinal chemistry, 2024-03, Vol.102, p.117671-117671, Article 117671

2024

Link zum Volltext

Verfügbarkeit prüfen

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Bioorganic & medicinal chemistry, 2021-10, Vol.47, p.116358-116358, Article 116358

2021

Link zum Volltext

Verfügbarkeit prüfen

Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors

Bioorganic & medicinal chemistry, 2023-08, Vol.91, p.117404-117404, Article 117404

2023

Link zum Volltext

Verfügbarkeit prüfen

1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117727-117727, Article 117727

2024

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biological evaluation of EGFR binding peptides for near-infrared photoimmunotherapy

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117717-117717, Article 117717

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I

Bioorganic & medicinal chemistry, 2023-12, Vol.96, p.117530-117530, Article 117530

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies

Bioorganic & medicinal chemistry, 2021-09, Vol.46, p.116384-116384, Article 116384

2021

Link zum Volltext

Verfügbarkeit prüfen

Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors

Bioorganic & medicinal chemistry, 2021-09, Vol.46, p.116367-116367, Article 116367

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.254

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBioorganic & Medicinal Chemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.254)
Mit Volltextzugriff
(1.254)

Publikationsform

Artikel
(1.254)

Sprache

Englisch
(1.254)
Japanisch
(204)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Drug Screening Assays, Antitumor
(1.235)
Chemistry
(1.193)
Chemistry, Medicinal
(1.191)
Chemistry, Organic
(1.191)
Life Sciences & Biomedicine
(1.191)
Pharmacology & Pharmacy
(1.191)
Physical Sciences
(1.191)
Science & Technology
(1.191)
Humans
(1.180)
Biochemistry & Molecular Biology
(1.105)
Antineoplastic Agents - Pharmacology
(884)
Structure-Activity Relationship
(864)
Antineoplastic Agents - Chemical Synthesis
(786)
Antineoplastic Agents - Chemistry
(760)
Cell Line, Tumor
(750)
Biological And Medical Sciences
(631)
Medical Sciences
(628)
Pharmacology. Drug Treatments
(617)
Molecular Structure
(597)
Cell Proliferation - Drug Effects
(594)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.254)
MEDLINE
(1.254)
IngentaConnect
(1.254)
Elsevier ScienceDirect Journals Complete
(1.254)
IngentaConnect Journals
(53)

Zeitschrift / Serie

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss

VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents

Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates

Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors

Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action

Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential

Synthesis, structural study and antitumor activity of novel alditol-based imidazophenanthrolines (aldo-IPs)

Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy

Regioselective synthesis and in vitro cytotoxicity evaluation of 3-thiooxindole derivatives: Tubulin polymerization inhibition and apoptosis inducing studies

Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents

Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors

Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents

Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer

Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones

Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds

Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells

Novel naphthoquinone-1H-1,2,3-triazole hybrids: Design, synthesis and evaluation as inductors of ROS-mediated apoptosis in the MCF-7 cells

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors

1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors

Synthesis and biological evaluation of EGFR binding peptides for near-infrared photoimmunotherapy

Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies

Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors

Aktive Filter

Suchergebnisse filtern